Composite hemangioendothelioma

Changed by Joachim Feger, 4 Sep 2021

Updates to Article Attributes

Body was changed:

Composite haemangioendotheliomas are locally aggressive and rarely metastasising vascular tumours consisting of different and histologically distinct elements.

Epidemiology

Composite haemangioendotheliomas are very rare and mostly seen in adults. Women are slightly more commonly affected 1,2.

Clinical presentation

The typical complaint is a lump with a reddish to purple appearance which has been there for a long time 1.

Associations

Composite haemangioendotheliomas are seen in patients with lymphoedema 1

Pathology

Composite haemangioendotheliomas are formed by at least two histologically different vascular tumour components. These parts often resemble retiform or epithelioid haemangioendotheliomas 1.

Aetiology

Chronic lymphoedema and irradiation are thought to have a role in the aetiology 1.

Subtypes

Neuroendocrine composite haemangioendothelioma is the only subtype.

Location

Composite haemangioendotheliomas most frequently affect the skin and subcutaneous tissues of the distal extremities or the head and neck area but have been also found in other sites 1,2

Macroscopic appearance

Macroscopically composite haemangioendotheliomas are nodular infiltrative ill-defined lesions 1,2

Microscopic appearance

The microscopic spectrum of composite haemangioendotheliomas consists of a composition of different morphological vascular components and areas including the following 1,2:

Neuroendocrine composite haemangioendotheliomas are typically composed of epithelioid and retiform haemangioendothelioma-like parts with a nest-like appearance 1.

ImmunohistochemistryImmunophenotype

Immunohistochemistry stains usually express CD31, ERG and FLI1 and can be positive CD34 and D2-40 1.

Genetics

Fusions of the PTBP1-MAML2 and EPC1-PCH2 genes have been observed in neuroendocrine composite haemangioendotheliomas 1.

Radiographic features

MRI

Composite haemangioendotheliomas are vascular lesions with a lobulated and heterogeneous appearance 2-4

Signal characteristics
  • T1: low to intermediate signal intensity
  • T2: high signal intensity
  • T2FS/STIR: high signal
  • T1 C+ (Gd): avid enhancement 

Radiology report

The radiological report should include a description of the following features:

  • form, location and size
  • tumour margins
  • relation to the muscular fascia
  • relationship to bones, tendons and joints
  • relationship to local nerves and vessels

Treatment and prognosis

Due to the rarity of the tumours, there is no clear management strategy as yet. Treatment usually consists of surgical excision. Local recurrence is common and can happen multiple times. Lymph node metastases can occur. Distant metastases are seen in neuroendocrine composite haemangioendotheliomas, which are more aggressive 1.

History and etymology

Composite haemangioendotheliomas were first described in 2000 by SJ Nayler 5.

Differential diagnosis

The differential diagnosis of composite haemangioendotheliomas consists of the following:

  • -</ul><p>Neuroendocrine composite haemangioendotheliomas are typically composed of epithelioid and retiform haemangioendothelioma-like parts with a nest-like appearance <sup>1</sup>.</p><h5>Immunohistochemistry</h5><p>Immunohistochemistry stains usually express CD31, ERG and FLI1 and can be positive CD34 and D2-40 <sup>1</sup>.</p><h5>Genetics</h5><p>Fusions of the <em>PTBP1-MAML2</em> and <em>EPC1-PCH2</em> genes have been observed in neuroendocrine composite haemangioendotheliomas <sup>1</sup>.</p><h4>Radiographic features</h4><h5>MRI</h5><p>Composite haemangioendotheliomas are vascular lesions with a lobulated and heterogeneous appearance <sup>2-4</sup>. </p><h6>Signal characteristics</h6><ul>
  • +</ul><p>Neuroendocrine composite haemangioendotheliomas are typically composed of epithelioid and retiform haemangioendothelioma-like parts with a nest-like appearance <sup>1</sup>.</p><h5>Immunophenotype</h5><p>Immunohistochemistry stains usually express CD31, ERG and FLI1 and can be positive <a title="CD34" href="/articles/cd34">CD34</a> and D2-40 <sup>1</sup>.</p><h5>Genetics</h5><p>Fusions of the <em>PTBP1-MAML2</em> and <em>EPC1-PCH2</em> genes have been observed in neuroendocrine composite haemangioendotheliomas <sup>1</sup>.</p><h4>Radiographic features</h4><h5>MRI</h5><p>Composite haemangioendotheliomas are vascular lesions with a lobulated and heterogeneous appearance <sup>2-4</sup>. </p><h6>Signal characteristics</h6><ul>

References changed:

  • 1. Rubin BP, Folpe AL. Composite haemangioendothelioma. In: WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 3). <a href="https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Soft-Tissue-And-Bone-Tumours-2020">https://publications.iarc.fr</a>
  • 2. Chin S, Kim J, Jung M et al. Intramuscular Composite Hemangioendothelioma: Case Report of an Unusual Tumor in an Unusual Location. Int J Clin Exp Pathol. 2020;13(6):1421-5. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344001">PMC7344001</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/32661479">Pubmed</a>
  • 3. Wildgruber M, Sadick M, Müller-Wille R, Wohlgemuth W. Vascular Tumors in Infants and Adolescents. Insights Imaging. 2019;10(1):30. <a href="https://doi.org/10.1186/s13244-019-0718-6">doi:10.1186/s13244-019-0718-6</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/30868300">Pubmed</a>
  • 4. Gok S, Berkman M, Baykara E. Composite Hemangioendothelioma Settled in the Paraspinal Region: A Rare Case Report. Turk Neurosurg. 2018;30(2):299-302. <a href="https://doi.org/10.5137/1019-5149.jtn.22256-17.4">doi:10.5137/1019-5149.jtn.22256-17.4</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/29757449">Pubmed</a>
  • 5. Nayler S, Rubin B, Calonje E, Chan J, Fletcher C. Composite Hemangioendothelioma. Am J Surg Pathol. 2000;24(3):352-61. <a href="https://doi.org/10.1097/00000478-200003000-00003">doi:10.1097/00000478-200003000-00003</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/10716148">Pubmed</a>
  • 1. W.H.O. Classification WHO Classification of Tumours Editorial Board, Who Classification of Tumours Editorial. Soft Tissue and Bone Tumours. (2020) <a href="https://books.google.co.uk/books?vid=ISBN9789283245025">ISBN: 9789283245025</a><span class=“ref_v4”></span>
  • 2. Chin S, Kim J, Jung MJ, Kim MJ, Moon A, Kim HK, Kim YH, Koh ES. Intramuscular composite hemangioendothelioma: case report of an unusual tumor in an unusual location. (2020) International journal of clinical and experimental pathology. 13 (6): 1421-1425. <a href="https://www.ncbi.nlm.nih.gov/pubmed/32661479">Pubmed</a> <span class=“ref_v4”></span>
  • 3. Wildgruber M, Sadick M, Müller-Wille R, Wohlgemuth WA. Vascular tumors in infants and adolescents. (2019) Insights into imaging. 10 (1): 30. <a href="https://doi.org/10.1186/s13244-019-0718-6">doi:10.1186/s13244-019-0718-6</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/30868300">Pubmed</a> <span class=“ref_v4"></span>
  • 4. Gok S, Berkman MZ, Baykara E. Composite Hemangioendothelioma Settled in the Paraspinal Region: A Rare Case Report. (2020) Turkish neurosurgery. 30 (2): 299-302. <a href="https://doi.org/10.5137/1019-5149.JTN.22256-17.4">doi:10.5137/1019-5149.JTN.22256-17.4</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/29757449">Pubmed</a> <span class="ref_v4"></span>
  • 5. Nayler SJ, Rubin BP, Calonje E, Chan JK, Fletcher CD. Composite hemangioendothelioma: a complex, low-grade vascular lesion mimicking angiosarcoma. (2000) The American journal of surgical pathology. 24 (3): 352-61. <a href="https://doi.org/10.1097/00000478-200003000-00003">doi:10.1097/00000478-200003000-00003</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/10716148">Pubmed</a> <span class="ref_v4"></span>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.